DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 3Dr. Reddy's Laboratories
02 3Pharmathen SA
03 12care4
04 3ADVANZ PHARMA CANADA INC.
05 3Acino Pharma (Pty) Ltd
06 9Amdipharm Mercury Company Limited
07 12Amdipharm Mercury Debtco Limited
08 3Biological E
09 1Europharmadk Aps
10 2Farm Agon
11 3Institut Produits Synthèse (IPSEN) AB
12 6InvaGen Pharmaceuticals Inc
13 36Ipsen
14 16Medartuum
15 40ORIFARM GROUP AS
16 1Omnia L?kemedel Ab
17 5Paranova Pharmaceuticals Ab
18 5Pharmachim Ab
19 6Sun Pharmaceutical Industries Limited
20 3Unimedic AB
21 3Zentiva
01 9Injectable Solution In Pre-Filled Syringe
02 3Injection
03 9Injection fluid, resolution in the finished filled syringe
04 1Lanreotide 120Mg 1 Unit Parenteral Use
05 1Lanreotide 30Mg 1 Unit Parenteral Use Rp
06 1Lanreotide 60Mg 1 Unit Parenteral Use
07 1Lanreotide 90Mg 1 Unit Parenteral Use
08 3Long Acting Injectable
09 3PFS
10 1Powder And Solvent For Extended-Release Injectable Suspension
11 1Powder For Injection
12 3Pre Filled Syringe
13 6SOLUTION (EXTENDED RELEASE)
14 9SOLUTION;SUBCUTANEOUS
15 81Solution For Injection
16 3Solution For Injection For Subcutaneous
17 3Solution For Injection In Pre-Filled
18 2Solution for injection, solution in pre-filled syringe
19 24Blank
01 3Allowed
02 38Approved
03 9Authorized
04 1Cancelled
05 41Deregistered
06 3EU Approved
07 3Lead Market Dossiers- Under Development
08 3Originator
09 6Prescription
10 9RX
11 48Blank
01 3IPSTYL
02 9Ipstyl
03 10Ipstyl Autogel
04 6LANREOTIDE ACETATE
05 3Lanreotida Sun
06 3Lanreotide Amdipharm
07 3Lanreotide Orifarm
08 3Lanreotide Sun
09 3Lanreotide Zentiva
10 3MYRELEZ
11 3MYTOLAC
12 5Myrelez
13 12Mytolac
14 3SOMATULINE AUTOGEL
15 1SOMATULINE AUTOGEL 120
16 1SOMATULINE AUTOGEL 60
17 1SOMATULINE AUTOGEL 90
18 3SOMATULINE DEPOT
19 1Somatulina
20 16Somatulina Autogel
21 62Somatuline Autogel
22 1Somatuline Pr
23 9Blank
01 24Australia
02 6Canada
03 3Greece
04 6India
05 10Italy
06 11Norway
07 3South Africa
08 10Spain
09 79Sweden
10 3Switzerland
11 9USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 60MG/0.2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 60MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 90MG/0.3ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 120MG/0.5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 90MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 120MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML)
Packaging :
Approval Date : 2021-12-17
Application Number : 215395
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML)
Packaging :
Approval Date : 2021-12-17
Application Number : 215395
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)
Packaging :
Approval Date : 2021-12-17
Application Number : 215395
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML)
Packaging :
Approval Date : 2024-05-21
Application Number : 217193
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML)
Packaging :
Approval Date : 2024-05-21
Application Number : 217193
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)
Packaging :
Approval Date : 2024-05-21
Application Number : 217193
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SOMATULINE DEPOT
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML)
Packaging :
Approval Date : 2007-08-30
Application Number : 22074
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SOMATULINE DEPOT
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML)
Packaging :
Approval Date : 2007-08-30
Application Number : 22074
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SOMATULINE DEPOT
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)
Packaging :
Approval Date : 2007-08-30
Application Number : 22074
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Ipstyl
Dosage Form : Lanreotide 120Mg 1 Unit Parenteral Use
Dosage Strength : 1 syringe SC 120 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Ipstyl
Dosage Form : Lanreotide 30Mg 1 Unit Parenteral Use Rp
Dosage Strength : 1 bottle IM 30 mg prolonged release + 1 Vial 2 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Ipstyl
Dosage Form : Lanreotide 60Mg 1 Unit Parenteral Use
Dosage Strength : 1 syringe SC 60 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Ipstyl
Dosage Form : Lanreotide 90Mg 1 Unit Parenteral Use
Dosage Strength : 1 syringe SC 90 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Ipstyl
Dosage Form : Injection fluid, resolution in the finished filled syringe
Dosage Strength : 120 mg
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
